Glaxo's new doc-pay policy mostly pleases critics




Another veteran of the Big Pharma wars questions the timing of GlaxoSmithKline's decision not to pay physician educators. Such speaking gigs are on the wane, at least in his experience, said Gary Sobelson, MD, a family physician in Concord, New Hampshire.
CLICK TO VIEW THE SOURCE MATERIAL


Post a comment


You must sign in before you can post comments. If you are experiencing issues with your account please e-mail abuse@unionleader.com.